These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33813319)

  • 1. Mills' syndrome: Reporting the disease course with a monthly intravenous immunoglobulin program.
    Algahtani H; Shirah B; Algahtani S; Attar A; Abuzinadah AR
    J Neuroimmunol; 2021 Jun; 355():577562. PubMed ID: 33813319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mills' syndrome: a rare clinical entity].
    Lachaud S; Soriani MH; Delmont E; Budai M; Desnuelle C; Lebrun C
    Rev Neurol (Paris); 2007 Mar; 163(3):335-40. PubMed ID: 17404520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mills' syndrome revisited.
    Jaiser SR; Mitra D; Williams TL; Baker MR
    J Neurol; 2019 Mar; 266(3):667-679. PubMed ID: 30631918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mills' syndrome is a unique entity of upper motor neuron disease with N-shaped progression: Three case reports.
    Zhang ZY; Ouyang ZY; Zhao GH; Fang JJ
    World J Clin Cases; 2022 Jul; 10(19):6664-6671. PubMed ID: 35979278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mills' syndrome].
    Turgunkhujaev OE; Kupreychik VL; Brand PY; Bril EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(10):138-142. PubMed ID: 36279241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is IVIg therapy warranted in progressive lower motor neuron syndromes without conduction block?
    Simon NG; Ayer G; Lomen-Hoerth C
    Neurology; 2013 Dec; 81(24):2116-20. PubMed ID: 24212395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mills' and other isolated upper motor neurone syndromes: in vivo study with 11C-(R)-PK11195 PET.
    Turner MR; Gerhard A; Al-Chalabi A; Shaw CE; Hughes RA; Banati RB; Brooks DJ; Leigh PN
    J Neurol Neurosurg Psychiatry; 2005 Jun; 76(6):871-4. PubMed ID: 15897516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate mofetil as adjunctive therapy for MMN patients: a randomized, controlled trial.
    Piepers S; Van den Berg-Vos R; Van der Pol WL; Franssen H; Wokke J; Van den Berg L
    Brain; 2007 Aug; 130(Pt 8):2004-10. PubMed ID: 17626040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting a positive response to intravenous immunoglobulin in isolated lower motor neuron syndromes.
    Burrell JR; Yiannikas C; Rowe D; Kiernan MC
    PLoS One; 2011; 6(10):e27041. PubMed ID: 22066029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Monthly low-dose immunoglobulin infusion as a maintenance therapy for multifocal motor neuropathy may reduce allergic adverse effects: a case report].
    Murata Y; Okamoto T; Kondo Y; Chihara N; Furusawa Y; Murata M
    Rinsho Shinkeigaku; 2010 Aug; 50(8):561-5. PubMed ID: 20803965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifocal motor neuropathy: clinical and immunological features and response to IVIg in relation to the presence and degree of motor conduction block.
    Nobile-Orazio E; Cappellari A; Meucci N; Carpo M; Terenghi F; Bersano A; Priori A; Barbieri S; Scarlato G
    J Neurol Neurosurg Psychiatry; 2002 Jun; 72(6):761-6. PubMed ID: 12023421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy.
    Cats EA; van der Pol WL; Piepers S; Franssen H; Jacobs BC; van den Berg-Vos RM; Kuks JB; van Doorn PA; van Engelen BG; Verschuuren JJ; Wokke JH; Veldink JH; van den Berg LH
    Neurology; 2010 Aug; 75(9):818-25. PubMed ID: 20805527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Exfoliative dermatitis as a side effect of intravenous immunoglobulin treatment].
    Markvardsen LH; Jakobsen J
    Ugeskr Laeger; 2011 Oct; 173(43):2725-6. PubMed ID: 22027232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic yield and cost-effectiveness of investigations in patients presenting with isolated lower motor neuron signs.
    Alanazy MH; White C; Korngut L
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Sep; 15(5-6):414-9. PubMed ID: 24863134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mills' Syndrome (Ascending Spastic Hemiparesis) Progressing to Corticobasal Syndrome.
    Mirian A; Romsa J; Jenkins ME; Budhram A
    Can J Neurol Sci; 2021 Nov; 48(6):852-853. PubMed ID: 33472710
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of human intravenous immunoglobulin in lower motor neuron syndromes.
    Ellis CM; Leary S; Payan J; Shaw C; Hu M; O'Brien M; Leigh PN
    J Neurol Neurosurg Psychiatry; 1999 Jul; 67(1):15-9. PubMed ID: 10369816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical variants of amyotrophic lateral sclerosis: hemiplegic type of ALS and Mills syndrome. A critical review].
    Malin JP; Poburski R; Reusche E
    Fortschr Neurol Psychiatr; 1986 Apr; 54(4):101-5. PubMed ID: 3710405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment.
    Van den Berg-Vos RM; Franssen H; Wokke JH; Van den Berg LH
    Brain; 2002 Aug; 125(Pt 8):1875-86. PubMed ID: 12135977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifocal motor neuropathy: decrease in conduction blocks and reinnervation with long-term IVIg.
    Vucic S; Black KR; Chong PS; Cros D
    Neurology; 2004 Oct; 63(7):1264-9. PubMed ID: 15477549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multifocal motor neuropathy: a retrospective study of the response to high-dose intravenous immunoglobulin (IVIg) and current perspectives for diagnosis and treatment].
    Léger JM; Viala K; Maisonobe T; Bouche P
    Bull Acad Natl Med; 2007 Oct; 191(7):1395-407; discussion 1407-9. PubMed ID: 18447061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.